Skip to content

Laboratory Smoking of Marijuana Blunts

Laboratory Smoking of Marijuana Blunts

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03546790
Enrollment
8
Registered
2018-06-06
Start date
2019-04-10
Completion date
2019-09-30
Last updated
2019-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis

Keywords

Cannabis

Brief summary

This is a double-blind within-subjects clinical laboratory study comparing the product appeal and abuse liability-related subjective effects of different flavored cigar wrappers for marijuana blunts.

Interventions

DRUGMarijuana

Marijuana smoked via blunts with different cigar wrappers

Sponsors

Battelle Memorial Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Currently living in Baltimore City or Baltimore County, MD; * Able to read, understand, and sign informed consent; * 18-55 years old; * Currently smokes marijuana blunts; * Designation of Medically Healthy for Research by the Study Physician; and * Willing to abstain from illicit drug use other than marijuana for the duration of the study.

Exclusion criteria

* BAC \> 0.020% as measured by alcohol breathalyzer; * Meets DSM-5 criteria for severe current or lifetime Cannabis Use Disorder; * Meets DSM-5 criteria for any current Axis I disorder, other than current mild or moderate Cannabis Use Disorder; * Self-reported current desire to stop marijuana use; * Self-reported current asthma, chronic obstructive pulmonary disease, hypertension, cardiovascular disease or any other medical illness that precludes participation; * Has difficulties with blood draws or poor venous access; * History of blood donation in the past 30 days or receiving blood products within the past 2 months prior to any experimental visit; * Among females, current pregnancy or lactation or attempting to get pregnant, or at risk of becoming pregnant; * Acute illness which will require participant to be rescheduled

Design outcomes

Primary

MeasureTime frameDescription
Puff topographyDuring marijuana blunt smokingTotal inhalation volume

Secondary

MeasureTime frameDescription
Carbon monoxideImmediately after marijuana blunt smokingExhaled breath carbon monoxide (ppm)
Subjective drug effectsImmediately after marijuana blunt smokingRatings of good and high
Measures of demandImmediately after marijuana blunt smokingNumber of units an individual would purchase at varying price points

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026